Abstract 5615: ALRN-0192519 is a potent and selective EGFR L858R mutation inhibitor that demonstrates anti-cancer activity in preclinical cancer models as monotherapy or in combination with osimertinibJiaqi Liang, Lina Gu, Yezhen Zhang et al.|Cancer Research|2025Cited by 0
Abstract LB460: Characterization of ARTS-051, a potent and selective Werner helicase inhibitor effective against a broad range of MSI-H colorectal cancer modelsChristine Moomau, Xiang Zhai, Wenheng Liang et al.|Cancer Research|2026Cited by 0